Related Experiment Video
Updated: May 28, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
E-Cigarette, Nicotine Pouch, and Other Oral Nicotine Product Concept Flavor Use Descriptives and Associations with
Tyler B Mason1,2, Dayoung Bae2,3, Alyssa F Harlow2,3
1Department of Nutrition and Food Studies, George Mason University, Fairfax, Virginia, USA.
Background:
Descriptives and correlates of concept flavor (CF) use across e-cigarettes, nicotine pouches, and other oral nicotine products (ONPs, e.g., nonmedicinal gums/lozenges/mints) were examined among adolescents and young adults (AYAs).
Method:
AYAs aged 14-25 years old ever having used a tobacco product (N = 987) were surveyed in May-June 2024. AYAs ever using e-cigarettes (n = 684), nicotine pouches (n = 347), or other ONPs (n = 189) completed measures of CF use and other factors for the products they reported using. Analyses included chi-square and t-tests.
Results:
CF e-cigarette, nicotine pouch, and other ONP use was between 31.8 and 40.2% in AYAs who ever used each respective product; 3.3% reported CF use across all products. Most perceived that CF products used produced non-tobacco sensations (fruity/cooling/minty; 79.5-96.4%). Compared to lifetime nonuse of respective products, lifetime alcohol and cigarette, smokeless, and other tobacco use were associated with CF e-cigarette use; smokeless tobacco use was associated with CF nicotine pouches and other ONPs use. CF e-cigarette use associated with higher e-cigarette use frequency and intensity compared to nonuse.
Conclusions:
AYA CF use spans several noncombustible nicotine products, produces fruity/cooling/minty sensations, and is associated with higher intensity vaping and substance co-use. Modifying regulatory policies to address CFs might protect AYAs.
More Related Videos
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Oral Drug Delivery Systems: Introduction
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Taste Buds and Receptors
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
The Tongue and Taste Buds

